Exela Pharma Sciences LLC recalls Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL), 100 mL Single-Dose Vial, 25 count carton, Ready to U
Recalled November 29, 2023 · FDA recall D-0117-2024 · Exela Pharma Sciences
Hazard
Presence of Particulate Matter: Silicone · FDA Class I
Units
23,425 vials
Sold at
Nationwide
Description
Presence of Particulate Matter: Silicone
Product
Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL), 100 mL Single-Dose Vial, 25 count carton, Ready to Use For Intravenous Infusion Only Preservative Free, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial NDC 51754-2131-1; Carton NDC 51754-2131-4).
Manufacturer(s)
Exela Pharma Sciences LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →